International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study

Marzieh Araghi; Miranda Fidler-Benaoudia; Melina Arnold; Mark Rutherford; Aude Bardot; Jacques Ferlay; Oliver Bucher; Prithwish De; Gerda Engholm; Anna Gavin; Serena Kozie; Alana Little; Bjørn Møller; Nathalie St Jacques; Hanna Tervonen; Paul Walsh; Ryan Woods; Dianne L O'Connell; David Baldwin; Mark Elwood; Sabine Siesling; Freddie Bray; Isabelle Soerjomataram; ICBP SURVMARK-2 Local Leads; ICBP SURVMARK-2 Academic Reference Group

doi:10.1136/thoraxjnl-2020-216555

Article info

Lung cancer

Original research

International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study

Authors

Marzieh Araghi Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France PubMed articles Google scholar articles
Miranda Fidler-Benaoudia Cancer Epidemiology and Prevention Research, Holy Cross Centre, Alberta Health Services, Calgary, Alberta, Canada PubMed articles Google scholar articles
Melina Arnold Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France PubMed articles Google scholar articles
Mark Rutherford Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France Health Sciences, University of Leicester, Leicester, UK PubMed articles Google scholar articles
Aude Bardot Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France PubMed articles Google scholar articles
Jacques Ferlay Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France PubMed articles Google scholar articles
Oliver Bucher Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada PubMed articles Google scholar articles
Prithwish De Analytics and Informatics, Cancer Care Ontario, Toronto, Ontario, Canada PubMed articles Google scholar articles
Gerda Engholm Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Kobenhavn, Denmark PubMed articles Google scholar articles
Anna Gavin Queen’s University Belfast, Northern Ireland Cancer Registry, Belfast, UK PubMed articles Google scholar articles
Serena Kozie Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada PubMed articles Google scholar articles
Alana Little Cancer Institute New South Wales, Eveleigh, New South Wales, Australia PubMed articles Google scholar articles
Bjørn Møller Department of Registration, Cancer Registry of Norway, Oslo, Norway PubMed articles Google scholar articles
Nathalie St Jacques Cancer Care Program, Registry and Analytics, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada PubMed articles Google scholar articles
Hanna Tervonen Cancer Institute New South Wales, Eveleigh, New South Wales, Australia PubMed articles Google scholar articles
Paul Walsh National Cancer Registry, Cork, Ireland PubMed articles Google scholar articles
Ryan Woods BC Cancer, Vancouver, British Columbia, Canada Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada PubMed articles Google scholar articles
Dianne L O'Connell The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Cancer Research Division, Sydney, New South Wales, Australia PubMed articles Google scholar articles
David Baldwin Respiratory Medicine Unit, David Evans Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK PubMed articles Google scholar articles
Mark Elwood School of Population Health, The University of Auckland, Auckland, New Zealand PubMed articles Google scholar articles
Sabine Siesling Department of Research and Development, IKNL, Utrecht, The Netherlands PubMed articles Google scholar articles
Freddie Bray Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France PubMed articles Google scholar articles
Isabelle Soerjomataram Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France PubMed articles Google scholar articles
ICBP SURVMARK-2 Local Leads
Google scholar articles
ICBP SURVMARK-2 Academic Reference Group
Google scholar articles
ICBP Clinical Committee–Lung
Google scholar articles

Correspondence to Dr Isabelle Soerjomataram, Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, 69372 CEDEX 08, France; soerjomatarami{at}iarc.fr

View Full Text

Citation

Araghi M, Fidler-Benaoudia M, Arnold M ICBP Clinical Committee–Lung, et al

International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study

Thorax 2022;77:378-390.

Publication history

Received November 18, 2020
Accepted June 7, 2021
First published July 19, 2021.

Online issue publication

September 01, 2022

Article Versions

Previous version (15 March 2022).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password